Alex Nascimento

Alex Nascimento is an experienced professional in project and portfolio management with a strong background in drug development and regulatory affairs. Currently serving as Director at Angitia Biopharmaceuticals since June 2023, Alex oversees the drug development pipeline and enhances team effectiveness. Prior experience includes roles at Amgen, where significant contributions were made as a Global Regulatory Affairs Senior Program/Project Manager and Global Development Operations Senior Project Manager, focusing on improving regulatory processes and clinical development operations. Additional experience encompasses program and project management positions with United Airlines, PricewaterhouseCoopers, and Petrobras America, Inc., leading initiatives in performance improvement, change management, and project controls. Alex holds an MBA from UCLA Anderson School of Management and a Master of Science in Analytics from the Georgia Institute of Technology.